Buying medicines can get confusing because the same tablet or syrup is often sold under different names and prices. Medicines come in two main forms: branded drugs and generic drugs. A branded drug is ...
The generic product is now available nationwide in strengths of 0.3mg, 0.45mg, 0.625mg, 0.9mg, and 1.25mg. The Food and Drug Administration (FDA) has approved the first generic version of Premarin ® ...
A new analysis has raised concerns about the Cigna Group’s drug pricing strategy, finding that one of its subsidiaries, Quallent Pharmaceuticals, often charges more for generic medications than ...
Jamie Dimon is right to be alarmed about our national-security vulnerabilities, especially an overreliance on China and India for generic prescription drugs (“Investments for National Security,” op-ed ...
Generic drugs are cheaper copies of brand drugs, offering significant savings to patients. Once a brand-name drug's patent expires, competitors can apply to make generic versions. Generic ...
Gilead Sciences, Inc. (NASDAQ:GILD) on Monday entered into settlement agreements to resolve the patent litigations with Lupin Ltd., Cipla Ltd. and Laurus Labs Ltd., generic manufacturers that filed ...
The N.C. House of Representatives voted in favor of the criminal justice package known as Iryna's Law on Tuesday, sending the bill to Gov. Josh Stein's desk including a controversial death penalty ...
US Securities and Exchange Commission Chair Paul Atkins says the new listing standards will reduce barriers to access digital asset products and give investors more choice. ”This approval helps to ...
The settlement agreement will extend market exclusivity for AbbVie’s JAK inhibitor in the U.S. until 2037—providing pediatric exclusivity is granted. AbbVie has reached a settlement with generic ...
BlackLine has ambitions to automate the Office of the CFO with AI, but not of the "generic dangerous" variety, says CTO Jeremy Ung. AI on its own isn't the product. Thank you Owen Ryan, co-CEO at ERP ...
ANDERLECHT, Belgium--(BUSINESS WIRE)--A.forall is pleased to announce the acquisition of four FDA-approved injectable generics and two late-stage pipeline assets from Provepharm's US portfolio. With ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback